Neonatal hyperoxia increases airway reactivity and inflammation in adult mice

Pediatric Pulmonology

Volumn 51, Issue 11, 2016, Pages 1131-1141

  Kumar, Vasantha H S ^a   Lakshminrusimha, Satyan ^a   Kishkurno, Sergei ^a   Paturi, Babu S ^a   Gugino, Sylvia F ^a   Nielsen, Lori ^a   Wang, Huamei ^a   Ryan, Rita M ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

airway reactivity; cytokines; hyperoxia; inflammation; lymphocytes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LEUKOTRIENE B4; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; BIOLOGICAL MARKER; METHACHOLINE CHLORIDE; OXYGEN; VASCULOTROPIN A;

ADULT; AMBIENT AIR; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; MOUSE; MUSCLE THICKNESS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SMOOTH MUSCLE; ANIMAL; COMPLICATION; LUNG; LYMPHOCYTE; METABOLISM; PATHOPHYSIOLOGY; PNEUMONIA;

ANIMALS; ANIMALS, NEWBORN; BIOMARKERS; CHEMOKINE CCL2; HYPEROXIA; INTERLEUKIN-12; LUNG; LYMPHOCYTES; METHACHOLINE CHLORIDE; MICE; MUSCLE, SMOOTH; OXYGEN; PNEUMONIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84964601633     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23430     Document Type: Article

References (39)

1. Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 2006; 30:227–232.
2. Greenough A. Long-term pulmonary outcome in the preterm infant. Neonatology 2008; 93:324–327.
3. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 2010; 15:223–229.
4. Tschumperlin DJ, Boudreault F, Liu F. Recent advances and new opportunities in lung mechanobiology. J Biomech 2010; 43:99–107.
5. Ambalavanan N, Carlo WA, D'Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123:1132–1141.
6. Escobar GJ, Ragins A, Li SX, Prager L, Masaquel AS, Kipnis P. Recurrent wheezing in the third year of life among children born at 32 weeks’ gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life. Arch Pediatr Adolesc Med 2010; 164:915–922.
7. Brostrom EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med 2010; 104:362–370.
8. Vrijlandt EJ, Boezen HM, Gerritsen J, Stremmelaar EF, Duiverman EJ. Respiratory health in prematurely born preschool children with and without bronchopulmonary dysplasia. J Pediatr 2007; 150:256–261.
9. Landry JS, Chan T, Lands L, Menzies D. Long-term impact of bronchopulmonary dysplasia on pulmonary function. Can Respir J 2011; 18:265–270.
10. Landry JS, Tremblay GM, Li PZ, Wong C, Benedetti A, Taivassalo T. Lung function and bronchial hyperresponsiveness in adults born prematurely: a cohort study. Ann Am Thorac Soc 2016; 13:17–24.
11. Wang H, Jafri A, Martin RJ, Nnanabu J, Farver C, Prakash YS, MacFarlane PM. Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway. Am J Physiol Lung Cell Mol Physiol 2014; 307:L295–L301.
12. Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L936–L947.
13. O'Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 2008; 177:1103–1110.
14. Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol 2008; 83:237–244.
15. Papiris SA, Kollintza A, Karatza M, Manali ED, Sotiropoulou C, Milic-Emili J, Roussos C, Daniil Z. CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J Inflamm (Lond) 2007; 4:14.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–275.
17. Emery JL, Mithal A. The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood. Arch Dis Child 1960; 35:544–547.
18. Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol (1985) 2010; 108:412–421.
19. Russo RC, Garcia CC, Barcelos LS, Rachid MA, Guabiraba R, Roffe E, Souza AL, Sousa LP, Mirolo M, Doni A. et al. Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J Leukoc Biol 2011; 89:269–282.
20. Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr 2011; 23:167–172.
21. Regal JF, Lawrence BP, Johnson AC, Lojovich SJ, O'Reilly MA. Neonatal oxygen exposure alters airway hyper-responsiveness but not the response to allergen challenge in adult mice. Pediatr Allergy Immunol 2014; 25:180–186.
22. O'Reilly M, Hansbro PM, Horvat JC, Beckett EL, Harding R, Sozo F. Bronchiolar remodeling in adult mice following neonatal exposure to hyperoxia: relation to growth. Anat Rec (Hoboken) 2014; 297:758–769.
23. O'Reilly M, Harding R, Sozo F. Altered small airways in aged mice following neonatal exposure to hyperoxic gas. Neonatology 2014; 105:39–45.
24. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V, Thomas S, Stocks J. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010; 182:237–245.
25. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118:108–113.
26. Wang EE, Law BJ, Stephens D. Pediatric investigators collaborative network on infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126:212–219.
27. Christie PE, Henderson WR, Jr. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin Allergy Immunol 2002; 16:233–254.
28. Harizi H, Juzan M, Moreau JF, Gualde N. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J Immunol 2003; 170:139–146.
29. Planaguma A, Levy BD. Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signaling. Future Lipidol 2008; 3:697–704.
30. Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, Nishimura K, Itoh H, Izumi T. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 2000; 162:1518–1523.
31. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107:295–301.
32. Lee CG, Ma B, Takyar S, Ahangari F, Delacruz C, He CH, Elias JA. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011; 8:512–515.
33. Baraldo S, Lokar Oliani K, Turato G, Zuin R, Saetta M. The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem 2007; 14:2250–2256.
34. Veness-Meehan KA, Bottone FG, Jr., Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res 2000; 48:434–444.
35. 2-induced inhibition of lung septation. Am J Physiol Lung Cell Mol Physiol 2002; 283:L971–L980.
36. Boros V, Burghardt JS, Morgan CJ, Olson DM. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats. Am J Physiol 1997; 272:L433–L441.
37. Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999; 103:759–765.
38. Kauffman SL, Burri PH, Weibel ER. The postnatal growth of the rat lung. II. Autoradiography. Anat Rec 1974; 180:63–76.
39. Manji JS, O'Kelly CJ, Leung WI, Olson DM. Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol 2001; 281:L799–L806.